that exene also need special deep freeze suitcases which can be used for just 10 days. it also requires dry ice, which is a hazardous material. and few hospitals and pharmacies have ultra cold freezers at the company behind the job remains confident. we have already produced more than 20000000 doses in our cars, and to continue as we speak, producing more and more. this is why we said that the baby had to leave here, which is even there how many weeks we expect to actually 50000000 doses that you can distribute to the world. we spoke to a senior clinical lecturer at britain's university of exeter medical school. he says it's important for different vaccines to be created across the world to provide choice. well, it's very important to maintain what you would call the cold chain extremely important. otherwise, you are injecting people with substandard or the nature of vaccine, and it is a waste of time resources and everything else. so it is very, very important to make sure that the vaccines when they leave their live oratory, where it is made to where the patient is go

approved exene by the end of 2021. and it will be given to the countries that are part of the facility, not how can 192 of them roughly 20 percent of their needs for now. and that's actually really important because it's never been the case before that innovative vaccine technology has made its way from the laboratory, through the clinic, through a big multinational corporation or a chinese company or an indian company. and then out into global health it at roughly the same time that it's available in the united states, u.k. and europe. so in a sense, kovacs is a victory for those people who believe in multilateralism in transparency, you know, unfortunately there are 2 big standouts from kovacs. it's the united states and this and russia. unfortunately, they should join. well, it's interesting that neither of those 2 countries do, and both of those countries obviously have those vaccines. but if you know nothing about vaccines, not as much as you do and you're sitting here watching this, and you're looking at this roc

however has rebuffed that saying the announcement had nothing to do with politics exene is being developed together with german drugmaker bio and tech and if all goes well the majority of americans well we're see that in 2021 head of the election the prospect of a job was used to score political points. we will masters tribute in the backseat in just a few short weeks it will quickly eradicate the virus and wipe out the child to play once and for all if the doctors tell us that we should take it i'll be the 1st in line to take it absolutely but if donald trump tells us i said to him that we've taken i'm not taking it we heard from dr john dombrowski director of the washington pain center he says government should stop the political games and focus on educating people about vaccines the covert 1000 pandemic at least in the united states is been a political football a thing to her donald trump the economy they will play up and the other side is this is the same way so i think it's very scary that we're here which we're seeing this tremendous and tragic intersection between politics and scien

you have to remember that speed, it's just exene was made,, had to do with the fact that it was using a new technology, an m.r.i., any vaccine platform. and that's where we cut this feat down and wasn't that the safety was at there were corners cut in phase one or 2 trials. we will have to follow people once they are vaccinated. 3 years, like we do with all that scenes. but in the middle of a pandemic, we're going to get an emergency use authorization based on the safety data that we have so far. and it does look good and you think we have to continue to follow, as i said, to make sure nothing late longer term occurs. but i do think everything is it is pointing the right way when it comes to this vaccine amiss. are you concerned that there are no long term observations with this vaccine? i'm not concerned in the sense that any time we have a vaccine it gets approved and then we follow people out in what are called face for trial. so when the h.p.v. vaccine was that was approved, we didn't have 2 or 3 or 4 years of safety data, but we followed people even after it was approved and it e

pharmaceutical giant pfizer is filing for emergency authorization of its coronavirus exene in the united states. the company is one of many working to fight the spread of cove 19. and as alex mcgill of its reports, it is one of a few front runners that may help the pandemic. the bottles are full and ready to go. once given the green light, pfizer says that it could start shipping out its coronavirus vaccine within a couple of hours. if the value we have already produced, more than 20000000 doses in our warehouses and to continue as a state producing more and more the company promises to have 50000000 doses ready for distribution by the end of this year. and estimates that it will produce 1300000000 doses of the vaccine by the end of 2021. however, there is one major hurdle standing in the way that government approval in the us. that means getting the thumbs up from the food and drug administration and considering the fact that the vaccine is relatively new and has not had the time to pass the usual scrutiny. pfizer and its german partner beyond tech are asking for emergency approval to g

you have to remember that the speed it's just exene was made,, had to do with the fact that it was using a new technology, an m.r.i., any vaccine platform. and that's where we cut this feet down and wasn't that the safety was if there were corners cut in phase one or 2 trials, we will have to follow people once they are vaccinated. 3 years, like we do with all that, it seems. but in the middle of a pandemic, we're going to get an emergency use authorization based on the safety data that we have so far. and it does look good and you think we have to, to continue to follow as i said, to make sure nothing late longer term occurs. but i do think everything is it is pointing the right way when it comes to this vaccine amiss. are you concerned that there are no long term observations with this vaccine? i'm not concerned in the sense that any time we have a vaccine it gets approved and then we follow people out in what are called face for trial. so when the h.p.v. vaccine was that was approved, we didn't have 2 or 3 or 4 years of safety data, but we followed people even after it was approved an

you have to remember that speed, it's just exene was made, had to do with the fact that it was using a new technology, an m.r.i. name, vaccine platform. and that's where we cut the speed down and wasn't that the safety was if there were corners cut in phase one or 2 trials, we will have to follow people once they are vaccinated, 3 years, like we do with all the axioms. but in the middle of a pandemic, we're going to get an emergency use authorization based on the safety data that we have so far. and it does look good and you think we have to, to continue to follow as i said, to make sure nothing late longer term occurs. but i do think everything is it is pointing the right way when it comes to this vaccine amiss. are you concerned that there are no long term observations with this vaccine? i'm not concerned in the sense that any time we have a vaccine it gets approved and then we follow people out in what are called phase for trial. so when the h.p.v. vaccine was that was approved, we didn't have 2 or 3 or 4 years of safety data, but we followed people even after it was approved. and

data, we've seen phase one in face 2, and now face 3 days, you have to remember that speed, it's just exene was made,, had to do with the fact that it was using a new technology an m.r.i., any vaccine platform, and that's where we cut this feet out and wasn't that the safety was at there were corners cut in phase one or 2 trials. we will have to follow people once they are vaccinated. 3 years, like we do with all the axioms. but in the middle of a pandemic, we're going to get an emergency use authorization based on the safety data that we have so far. and it does look good and you think we have to continue to follow, as i said, to make sure nothing late longer term occurs. but i do think everything is it is pointing the right way when it comes to this vaccine amiss. are you concerned that there are no long term observations with this vaccine? i'm not concerned in the sense that any time we have a vaccine it gets approved and then we follow people out in what are called phase for trials. so when the h.p.v. vaccine was that was approved, we didn't have 2 or 3 or 4 years of safety data, but we